Market Tracker

02/27 6:02pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

16.22
Delayed Data
As of Feb 27
 +0.05 / +0.31%
Today’s Change
13.73
Today|||52-Week Range
23.95
-0.37%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close16.17
Today’s open16.18
Day’s range16.03 - 16.43
Volume268,674
Average volume (3 months)525,398
Market cap$529.2M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+30.16%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.92
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...-0.08-0.35%
EXELExelixis Inc0.000.00%
ARWRArrowhead Research C...-0.21-2.71%
LXRXLexicon Pharmaceutic...-0.00-0.33%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
Senior VP
Felicia Ladin
Corporate headquarters
Albany, New York

Forecasts